Caitlin Dickson

Follow on Linkedin

About

MSci (Hons) Immunology

University of Glasgow

Immuno-oncology, cell-killing assays, and flow cytometry.

Study Manager

Caitlin joined RoukenBio in 2022 as a Study Scientist, progressing to Study Manager in 2025.

She studied cancer immunology and autoinflammatory diseases at the University of Glasgow and graduated with an MSci (Hons) in Immunology. During her MSci work placement year, she researched the treatment of active paediatric Crohn’s disease with exclusive enteral nutrition.

Caitlin's role within the RoukenBio team is performing and managing a wide variety of immuno-oncology and cell-killing assays, specifically involving T cells, NK cells and macrophages.

Resources

Blog image - A Human-Relevant Ex Vivo IBD Model for Therapeutic Development and Preclinical Testing.png

Insights

5 August 2026

5 min read

A Human-Relevant Ex Vivo IBD Model for Therapeutic Development and Preclinical Testing

Explore how RoukenBio’s patient-derived ex vivo IBD model preserves key tissue compartments to support more clinically relevant therapeutic testing for Crohn’s disease and ulcerative colitis.